User description
CD BioSciences has a representative technology of the most significant advancements in VLP production: VLPlant™ platform. Developed to leverage the advantages of plant-based expression systems, the VLPlant™ provides a unique and innovative approach to VLP production. Traditional methods of VLP production often involve cell cultures derived from animal cells, which can be costly and pose various regulatory challenges. In contrast, the VLPlant™ platform employs genetically modified plants to produce VLPs, offering a more sustainable and potentially less expensive alternative.Latest listings
-
Advancements in Virus-Like Particles Production Services Using the VLPlant™ PlatformCheck with sellerTechnology 2024/11/26In biotechnology and pharmaceutical development, the demand for effective vaccine platforms has surged dramatically in recent years, particularly in response to global health crises such as the COVID-19 pandemic. Among the various solutions being exp...Clicks 12 | 3 weeks ago
- 1